First promising clinical results of the combination of Wee1 inhibition and irradiation have already been achieved in a phase 1 clinical trial combining adavosertib with radiotherapy and gemcitabine in pancreatic cancer in line with a previous preclinical study [21–23]. This evidence concerns the gene WEE1 and pancreatic neoplasm.